The stimulus for the migration of polymorphonuclear leukocytes (PMNs) in acute chlamydial infection was studied in vitro by examining the chemotaxigenic effect of L2 and DE Chlamydia trachomatis elementary bodies (EB) upon the plasma of three healthy donors. In each individu.l experiment, chemotactic response was assessed with PMNs and plasma from the same respective donor, and no specific antibodies against C. trachomatis were detected in the plasma of any donor. Chemotaxis was observed in an agarose plate assay and was quantitated as the chemotactic differential, or CD (directed migration of PMNs minus random movement of PMNs). For each donor, the mean CD was significantly greater (P < 0.005) when plasma preincubated for 2 h with L2 EB was used as the chemoattractant than when (i) plasma alone, (ii) plasma preheated to 56°C for 30 min before incubation with L2 EB, or (iii) L2 EB in phosphate-buffered saline (PBS) was used as the potential chemoattractant. Similarly, in the one donor in whom DE EB were studied, the mean CD was also significantly greater (P < 0.005) for plasma preincubated with DE EB as compared with (i) plasma alone or (ii) DE EB in PBS. Complement activation by C. trachomatis EB was assessed by radioimmunoassay for C5a des-arginine in all chemoattractant preparations used in the chemotaxis assay. Mean C5a des-arginine levels were high in plasma samples preincubated with L2 EB (171.00 ± 10.64, 107.00 ± 4.76, and 89.70 ± 1.74 ng per ml) or DE EB (37.40 ± 15.76 ng per ml) but were undetectable (<4.0 ng per ml) in (i) plasma alone, (ii) preheated plasma incubated with L2 EB, and (iii) PBS containing L2 EB. Thus, L2 EB and DE EB of C. trachomatis exert a chemotaxigenic effect upon normal antibody-negative plasma, and this effect is at least in part a result of complement activation and generation of the potent chemotaxin C5a.
In the past decade, Chlamydia trachomatis has been identified as a significant and frequent human pathogen. C. trachomatis is now recognized to be a major cause of sexually transmitted genitourinary disease and has been associated with urethritis, epididymitis, and proctitis in the male and"acute urethral syndrome," cervicitis, salpingitis, and perihepatitis in the female (2) . It is also an important pathogen in neonates and may result in conjunctivitis or pneumonia in this setting (10) . In addition, certain serovars are responsible for specific disease entities, such as trachoma and lymphogranuloma venereum (2) .
Although C. trachomatis is an obligate intracellular bacterium, there is an intense inflammatory response to infection with this organism. In the initial phase, the cellular component of this response consists primarily of polymorphonuclear leukocytes (PMNs) and macrophages (13, 14) . Yong et al. (24) demonstrated in vitro that PMNs were capable of phagocytosing and killing elementary bodies (EB) of C. trachomatis, but little else is known about the interaction of this organism with PMNs. In addition, the interaction between C. trachomatis and other components of the acute inflammatory response, such as the complement system, have received limited study.
The objective of this study was To account for the random movement of PMNs, the chemotactic differential (CD) was calculated for each series of three wells. This was the distance of PMN migration towards the chemoattractant well minus the random movement of PMNs in the direction of the inner control buffer well. For each chemoattractant preparation, a total of 18 series of three wells (three agarose plates) was observed, and the mean CD was calculated.
C5a des Arg assay. Human complement 1251-labeled C5a des-arginine (CSa des Arg) radioimmunoassay kits were employed to measure C5a des Arg levels in all chemoattractant preparations used in the chemotaxis assay. These kits were provided as a gift by the Upjohn Co., Kalamazoo, Mich. CSa des Arg is the degradation product of CSa and is formed after C5a is rapidly acted upon by a carboxypeptidase-N enzyme (anaphylatoxin inactivator) that is found in normal plasma and serum (1) . C5a is the small fragment of C5 that is released into the fluid phase when C5 is cleaved as a result of alternative or classical complement pathway activation. C5a is also the most potent chemotactic factor for PMNs in the complement cascade (8).
Statistical comparisons. All statistical comparisons were done by a two-tailed Student t test.
RESULTS
Chemotaxis assay. The chemotaxis assay results for three healthy C. trachomratis antibody-negative donors are shown in Table 1 . When plasma that was preincubated for 2 h with L2 EB was used as the chemoattractant, the mean CD was significantly greater than when (i) plasma alone, (ii) L2 EB incubated in preheated plasma (56°C for 30 min), or (iii) L2 EB in PBS was used as the chemoattractant. The difference was significant (P < 0.005) for each donor. Similarly, for the one donor in whom DE chlamydial EB were studied, the VOL. 49, 1985 mean CD was also significantly greater (P < 0.005) for plasma preincubated with DE EB than for plasma alone or DE EB in PBS. Zymosan-activated plasma was included as a positive comparison. Zymosan is a potent activator of the alternative complement pathway.
To ensure that the observed chemotaxigenic effect of C. trachomatis upon normal plasma was due to specifically the presence of EB and not contamination of the final suspension by nonspecific material (such as endotoxin or cell fragments) during the cell culture and purification process, control suspensions were also tested in the chemotaxis assay of two of the donors. These control suspensions were prepared by processing uninfected McCoy cell monolayers under the same conditions and techniques as required for the growth and partial purification of C. trachomatis EB. Preincubation of plasma with volumes of the control suspension equivalent to the volumes used of the EB preparations resulted in no significantly greater CD than when plasma alone or EB in PBS were used as chemoattractants.
C5a des Arg assay. Chemoattractant preparations used in the chemotaxis experiment were assayed for C5a des Arg levels ( Table 2 ). Plasma preincubated with L2 EB or DE EB demonstrated much higher C5a des Arg levels than did plasma alone or L2 EB in preheated plasma. In the latter two chemoattractant preparations, in fact, C5a des Arg levels were undetectable (<4.0 ng per ml) for all three donors. Plasma preincubated with the control suspension was also assayed for C5a des Arg for the two donors in whom this was studied. In Donor 1, there was no detectable C5a des Arg, while in Donor 3 the level was low but detectable at 8.31 + 1.99 ng per ml. This level, however, was significantly lower (P < 0.001) than that measured in plasma preincubated with L2 EB.
Although not shown in Table 2 , C5a des Arg levels were undetectable in the chemoattractant mixtures prepared by incubating L2 EB in PBS. The C5a des Arg levels mneasured in zymosan-activated plasma are shown for comparison. DISCUSSION We have shown in vitro that EB of C. trachomatis exert a chemotaxigenic effect upon normal human plasma. As this effect was abolished by preheating plasma to 56°C and since 
